Understanding the specificity of a docking interaction between JNK1 and the scaffolding protein JIP1.
The up-regulation of JNK activity is associated with a number of disease states. The JNK-JIP1 interaction represents an attractive target for the inhibition of JNK-mediated signaling. In this study, molecular dynamics simulations have been performed on the apo-JNK1 and the JNK1•L-pepJIP1 and JNK1•D-pepJIP1 complexes to investigate the interaction between the JIP1 peptides and JNK1. Dynamic domain studies based on essential dynamics (ED) analysis of apo-JNK1 and the JNK1•L-pepJIP1 complex have been performed to analyze and compare details of conformational changes, hinge axes, and hinge bending regions in both structures. The activation loop, the αC helix, and the G loop are found to be highly flexible and to exhibit significant changes in dynamics upon L-pepJIP1 binding. The conformation of the activation loop for the apo state is similar to that of inactive apo-ERK2, while the activation loop in JNK1•L-pepJIP1 complex resembles that of the inactive ERK2 bound with pepHePTP. ED analysis shows that, after the binding of l-pepJIP1, the N- and C-terminal domains of JNK1 display both a closure and a twisting motion centered around the activation loop, which functions as a hinge. In contrast, no domain motion is detected for the apo state for which an open conformation is favored. The present study suggests that L-pepJIP1 regulates the interdomain motions of JNK1 and potentially the active site via an allosteric mechanism. The binding free energies of L-pepJIP1 and D-pepJIP1 to JNK1 are estimated using the molecular mechanics Poisson-Boltzmann and generalized-Born surface area (MM-PB/GBSA) methods. The contribution of each residue at the interaction interface to the binding affinity of L-pepJIP1 with JNK1 has been analyzed by means of computational alanine-scanning mutagenesis and free energy decomposition. Several critical interactions for binding (e.g., Arg156/L-pepJIP1 and Glu329/JNK1) have been identified. The binding free energy calculation indicates that the electrostatic interaction contributes critically to specificity, rather than to binding affinity between the peptide and JNK1. Notably, the binding free energy calculations predict that D-pepJIP1 binding to JNK1 is significantly weaker than the L form, contradicting the previous suggestion that D-pepJIP1 acts as an inhibitor toward JNK1. We have performed experiments using purified JNK1 to confirm that, indeed, D-pepJIP1 does not inhibit the ability of JNK1 to phosphorylate c-Jun in vitro.
Department of Biomedical Engineering, University of Texas, Austin, Texas 78712, USA.
Chunli
C
Yan
Tamer
T
Kaoud
Sunbae
S
Lee
Kevin N
KN
Dalby
Pengyu
P
Ren
D048868:Adaptor Proteins, Signal Transducing / Q000737:chemistry*; D000494:Allosteric Regulation; D019943:Amino Acid Substitution; D020134:Catalytic Domain; D006801:Humans; D019950:Mitogen-Activated Protein Kinase 1 / Q000737:chemistry; D048055:Mitogen-Activated Protein Kinase 8 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D056004:Molecular Dynamics Simulation; D009154:Mutation; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D013816:Thermodynamics
D048868:Adaptor Proteins, Signal Transducing; C490666:MAPK8IP1 protein, human; D019950:Mitogen-Activated Protein Kinase 1; D048055:Mitogen-Activated Protein Kinase 8
J Chem Inf Model. 2009 Aug;49(8):1936-43
19594140
Physiol Rev. 2001 Apr;81(2):807-69
11274345
Science. 1995 Jan 20;267(5196):389-93
7824938
J Biol Chem. 2003 Aug 29;278(35):32618-30
12750372
J Comput Chem. 2007 Feb;28(3):644-54
17195156
Bioorg Med Chem Lett. 2009 Jan 15;19(2):360-4
19071018
Diabetes. 2001 Jan;50(1):77-82
11147798
Proteins. 2004 May 1;55(2):383-94
15048829
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3023-8
19204278
Mol Cell. 2004 Apr 9;14(1):43-55
15068802
J Comput Chem. 2005 Dec;26(16):1668-88
16200636
J Mol Graph Model. 2004 Oct;23(2):189-98
15363460
Science. 2002 Dec 6;298(5600):1912-34
12471243
Cell. 1997 Sep 5;90(5):859-69
9298898
Trends Mol Med. 2005 May;11(5):232-9
15882611
J Biol Chem. 1990 Oct 5;265(28):17355-63
2170374
Mol Cell. 2005 Dec 22;20(6):951-62
16364919
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
8744570
J Comput Chem. 2009 Aug;30(11):1701-11
19399779
J Phys Chem B. 2007 Aug 2;111(30):9104-13
17602517
Endocr Rev. 2001 Apr;22(2):153-83
11294822
Science. 1998 Sep 11;281(5383):1671-4
9733513
Nature. 2002 Nov 7;420(6911):102-6
12422224
Genes Dev. 1994 Dec 15;8(24):2996-3007
8001819
EMBO J. 1996 Jun 3;15(11):2760-70
8654373
J Mol Biol. 2004 Jun 4;339(3):515-25
15147839
J Biol Chem. 2002 Mar 29;277(13):10987-97
11790767
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2327-32
9122194
J Phys Chem B. 2006 Jun 8;110(22):10962-9
16771349
Science. 2002 Feb 15;295(5558):1291-4
11847341
J Immunol. 2001 May 1;166(9):5646-53
11313405
Proteins. 2008 Oct;73(1):134-49
18398905
J Med Chem. 2003 Dec 18;46(26):5628-37
14667217
J Am Chem Soc. 2005 Dec 14;127(49):17253-60
16332074
Proteins. 1997;Suppl 1:50-8
9485495
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1828-35
17158645
Science. 2006 Feb 10;311(5762):822-6
16424299
Biophys J. 2001 Aug;81(2):715-24
11463620
Proteins. 2007 May 1;67(2):418-34
17256770
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5326-31
16567630
J Neurochem. 1999 Apr;72(4):1335-43
10098834
J Mol Biol. 2001 Jul 27;310(5):1039-53
11501994
Structure. 1998 Aug 15;6(8):983-91
9739089
Biophys J. 2006 Sep 1;91(5):1823-31
16714351
EMBO J. 2001 Feb 1;20(3):466-79
11157753
J Comput Aided Mol Des. 2004 Jun;18(6):433-6
15663003
Mol Cell. 2002 Jun;9(6):1241-9
12086621
J Am Chem Soc. 2002 May 29;124(21):6153-61
12022850
Protein Sci. 2005 Oct;14(10):2487-98
16155203
Pharmacol Ther. 2002 Feb-Mar;93(2-3):193-202
12191611
Nature. 1994 Feb 24;367(6465):704-11
8107865
Biophys J. 2003 Jul;85(1):159-66
12829472
J Mol Biol. 2003 Jul 18;330(4):891-913
12850155
Trends Biochem Sci. 2000 Sep;25(9):448-53
10973059
Structure. 2006 Jun;14(6):1011-9
16765894
J Mol Graph Model. 2002 Dec;21(3):181-3
12463636
J Mol Biol. 2004 Jun 11;339(4):1001-21
15165865
EMBO J. 1998 Mar 16;17(6):1740-9
9501095
Nat Rev Drug Discov. 2003 Jul;2(7):554-65
12815381
EMBO J. 2004 Jun 2;23(11):2185-95
15141161
J Am Chem Soc. 2002 Sep 25;124(38):11258-9
12236726
Proteins. 2002 Feb 15;46(3):250-8
11835500
Curr Opin Struct Biol. 1999 Apr;9(2):164-9
10322205
Curr Opin Genet Dev. 2002 Feb;12(1):14-21
11790549
J Biol Chem. 2000 Oct 13;275(41):31588-93
10922375
Curr Biol. 1999 May 6;9(9):R329-31
10322109
Acc Chem Res. 2000 Dec;33(12):889-97
11123888
Nature. 1998 Sep 17;395(6699):237-43
9751050
J Comput Chem. 2003 Dec;24(16):1999-2012
14531054
Nature. 1998 Sep 17;395(6699):244-50
9751051
Brain Res Mol Brain Res. 1996 Jan;35(1-2):47-57
8717339
Cell. 1994 Mar 25;76(6):1025-37
8137421
J Mol Biol. 2008 Nov 21;383(4):885-93
18801372
J Biol Chem. 2006 Sep 8;281(36):26225-34
16849316